TORONTO -- A Quebec man who was on a popular antidepressant that is being withdrawn from the Canadian market has launched a $200-million class-action lawsuit against companies that make the drug and its generic brands. In a statement of claim filed this week in an Ontario court, Steve Ledyit, 36, said he was prescribed Serzone four years ago while living in Barrie, Ont., north of Toronto. Within months of beginning treatment, Ledyit developed symptoms that were eventually diagnosed as serious liver damage, says the 17-page document.
Posted by Editor at November 6, 2003 10:49 AM